Role of complement 3a in the growth of mesangial cells from stroke-prone spontaneously hypertensive rats

References

• Sen S, Tarazi RC, Khairallah PA, Bumpus FM. Cardiac hypertrophy in spontaneously hypertensive rats. Circ Res 1974;35:775–81
   PubMed Web of Science ®Google Scholar
• Folkow B. Structure and function of the arteries in hypertension. Am Heart J 1987;114:938–48
   PubMed Web of Science ®Google Scholar
• Folkow B. The fourth Volhard lecture: cardiovascular structural adaptation; its role in the initiation and maintenance of primary hypertension. Clin Sci Mol Med Suppl 1978;4:3S–22S
   PubMedGoogle Scholar
• Gray SD. Spontaneous hypertension in the neonatal rat. A review. Clin Exp Hypertens 1984;6:755–81
   Web of Science ®Google Scholar
• Walter SV, Hamet P. Enhanced DNA synthesis in heart and kidney of newborn spontaneously hypertensive rats. Hypertension 1986;8:520–5
   PubMed Web of Science ®Google Scholar
• Hadrava V, Tremblay J, Hamet P. Abnormalities in growth characteristics of aortic smooth muscle cells in spontaneously hypertensive rats. Hypertension 1989;13:589–97
   PubMed Web of Science ®Google Scholar
• Hu WY, Fukuda N, Kanmatsuse K. Growth characteristics, angiotensin II generation, and microarray-determined gene expression in vascular smooth muscle cells from young spontaneously hypertensive rats. J Hypertens 2002;20:1323–33
   PubMed Web of Science ®Google Scholar
• Fukuda N, Satoh C, Hu WY, et al. Production of angiotensin II by homogeneous cultures of vascular smooth muscle cells from spontaneously hypertensive rats. Arterioscler Thromb Vasc Biol 1999;19:1210–17
   PubMed Web of Science ®Google Scholar
• Fukuda N, Hu WY, Satoh C, et al. Contribution of synthetic phenotype on the enhanced angiotensin II-generating system in vascular smooth muscle cells from spontaneously hypertensive rats. J Hypertens 1999;17:1099–107
   PubMed Web of Science ®Google Scholar
• Hu WY, Fukuda N, Satoh C, et al. Phenotypic modulation by fibronectin enhances the angiotensin II-generating system in cultured vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2000;20:1500–5
   PubMed Web of Science ®Google Scholar
• Lin ZH, Fukuda N, Jin XQ, et al. Complement 3 is involved in the synthetic phenotype and exaggerated growth of vascular smooth muscle cells from spontaneously hypertensive rats. Hypertension 2004;44:42–7
   PubMed Web of Science ®Google Scholar
• Yao EH, Fukuda N, Ueno T, et al. Complement 3 activates KLF5 gene in vascular smooth muscle cells. Biochem Biophys Res Commun 2008;367:468–73
   PubMed Web of Science ®Google Scholar
• de Bruijn MH, Fey GH. Human complement component C3: cDNA coding sequence and derived primary structure. Proc Natl Acad Sci USA 1985;82:708–12
   PubMed Web of Science ®Google Scholar
• Sahu A, Lambris JD. Structure and biology of complement protein C3, a connecting link between innate and acquired immunity. Immunol Rev 2001;180:35–48
   PubMed Web of Science ®Google Scholar
• Schraufstatter IU, Discipio RG, Zhao M, Khaldoyanidi SK. C3a and C5a are chemotactic factors for human mesenchymal stem cells, which cause prolonged ERK1/2 phosphorylation. J Immunol 2009;182:3827–36
   Google Scholar
• Wan J, Fukuda N, Endo M, et al. Complement 3 is involved in changing the phenotype of human glomerular mesangial cells. J Cell Physiol 2007;213:495–501
   PubMed Web of Science ®Google Scholar
• Floege J, Burns MW, Alpers CE, et al. Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model. Kidney Int 1992;41:297–309
   PubMed Web of Science ®Google Scholar
• Pesce CM, Striker LJ, Peten E, et al. Glomerulosclerosis at both early and late stages is associated with increased cell turnover in mice transgenic for growth hormone. Lab Invest 1991;65:601–5
   PubMed Web of Science ®Google Scholar
• Welch TR. The complement system in renal diseases. Nephron 2001;88:199–204
   PubMedGoogle Scholar
• Zhou W, Marsh JE, Sacks SH. Intrarenal synthesis of complement. Kidney Int 2001;59:1227–35
   PubMed Web of Science ®Google Scholar
• Matsumoto K, Hatano M. Production of interleukin 1 in glomerular cell cultures from rats with nephrotoxic serum nephritis. Clin Exp Immunol 1989;75:123–8
   PubMed Web of Science ®Google Scholar
• Winer J, Jung CK, Shackel I, Williams PM. Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. Anal Biochem 1999;270:41–9
   PubMed Web of Science ®Google Scholar
• Tahira Y, Fukuda N, Endo M, et al. Expression of transforming growth factor-β in cardiovascular organs in stroke-prone spontaneously hypertensive rats during development of hypertension. Hypertens Res 2002;25:911–18
   PubMed Web of Science ®Google Scholar
• Holland MC, Morikis D, Lambris JD. Synthetic small-molecule complement inhibitors. Curr Opin Invest Drug 2004;5:1164–73
   PubMedGoogle Scholar
• Bakris GL, Palant CE, Walsh MF, Sowers JR. Analogy between endothelial/mesangial cell and endothelial/vascular smooth muscle cell interactions: role of growth factors and mechanotransduction. In: Sowers JR, ed. Endocrinology of the vasculature. Totowa, NJ: Humana Press; 1996:341–55
   Google Scholar
• Watanabe N, Kurabayashi M, Shimomura Y, et al. BTEB2, a Krüppel-like transcription factor, regulates expression of the SMemb/Nonmuscle myosin heavy chain B (SMemb/NMHC-B) gene. Circ Res 1999;85:182–91
   PubMed Web of Science ®Google Scholar
• Hong MH, Jin CH, Sato T, et al. Transcriptional regulation of the production of the third component of complement (C3) by 1 alpha, 25-dihydroxyvitamin D3 in mouse marrow-derived stromal cells (ST2) and primary osteoblastic cells. Endocrinology 1991;129:2774–9
   PubMed Web of Science ®Google Scholar
• Di Renzo L, Longo A, Morgante E, et al. C3 molecules internalize and enhance the growth of Lewis lung carcinoma cells. Immunobiology 1999;200:92–105
   PubMed Web of Science ®Google Scholar
• Hugli TE, Müller-Eberhard HJ. Anaphylatoxins: C3a and C5a. Adv Immunol 1978;26:1–53
   PubMedGoogle Scholar
• Rohrwasser A, Morgan T, Dillon HF, et al. Elements of a paracrine tubular renin--angiotensin system along the entire nephron. Hypertension 1999;34:1265–74
   PubMed Web of Science ®Google Scholar
• Moe OW, Ujiie K, Star RA, et al. Renin expression in renal proximal tubule. J Clin Invest 1993;91:774–9
   PubMed Web of Science ®Google Scholar
• Casarini DE, Boim MA, Stella RC, et al. Angiotensin I-converting enzyme activity in tubular fluid along the rat nephron. Am J Physiol 1997;272:F405–9
   PubMed Web of Science ®Google Scholar
• Glukhova MA, Frid MG, Kotelainsky VE. Developmental changes in expression of contractile and cytoskeletal proteins in human aortic smooth muscle. J Biol Chem 1990;265:13042–6
   PubMed Web of Science ®Google Scholar